Skip to main content

Jeff Lagasse

By Jeff Lagasse | 12:16 pm | April 29, 2020
Even when asked to suspect themselves infected, 9% would still avoid treatment, suggesting gaps in coverage or poor finances.
By Jeff Lagasse | 03:07 pm | April 28, 2020
Hospitals should be planning early for equipment, beds and people, and listening to epidemiologists about the kinds of numbers to expect.
By Jeff Lagasse | 11:22 am | April 28, 2020
Consumers may take a more active role in managing health and participating in a system that is essentially being remade.
By Jeff Lagasse | 02:58 pm | April 27, 2020
By automating certain data-driven tasks, administrative waste can be dramatically reduced and RCM operations can move more efficiently.
By Jeff Lagasse | 01:04 pm | April 27, 2020
Providers should seek ways to automate the process as much as possible to curtail the manual work involved.
By Jeff Lagasse | 02:55 pm | April 24, 2020
Gene therapy delivered through the adeno-associated virus is likely the most attractive alternative treatment until a vaccine is produced.
By Jeff Lagasse | 11:42 am | April 24, 2020
If 20% of the US population were to become infected with COVID-19, it would result in an average of $163.4 billion in direct medical costs.
By Jeff Lagasse | 03:25 pm | April 23, 2020
Attracting new business meant moving away from tried-and-true marketing initiatives and devising something more modern and personal.
By Jeff Lagasse | 12:32 pm | April 23, 2020
The new constant flow canopy system addresses the risk of infection by eliminating healthcare teams' exposure.
By Jeff Lagasse | 03:10 pm | April 22, 2020
Organizations should ensure standards of care are maintained despite the increase in healthcare utilization.